Pharma Journalist -

European Patent Office grants Intent-to-Grant notice to biotechnology company specializing in the development of innovative drugs in oncology, in particular against rare or resistant…
Read More...

European Medicines Agency asserted that Alnylam Pharmaceutical's application for Marketing Authorisation has been accepted for review of for patisiran, an investigational RNAi…
Read More...

3D Cell Culture Conference - 21 - 22nd February 3D bioprinting and other biofabrication methods Workshop – 20th February Copthorne Tara Hotel Kensington, London,UK…
Read More...

Japan's Ministry of health, labor and Welfare extended marketing and manufacturing authorization for Regeneron's DUPIXENT for the treatment of atopic dermatitis in adults not curbed by…
Read More...

Chinese Center for Drug Evaluation has sanctioned an expansion of  expansion of the indications for Aggrastat for pharmaceutical company focused on commercializing patent-protected…
Read More...

Clinical-stage, biotherapeutics company, SillaJen committed to the development of oncolytic immunotherapy products for Cancer and ABL Europe company providing dedicated viral vector GMP…
Read More...

Ligand Pharmaceuticals asserted that it has forayed into a worldwide OmniAb platform license agreement with Ferring Pharmaceuticals. As per the terms of the agreement, Ferring…
Read More...

Astellas Pharma confirmed acquisition of MitoBridge. Astellas shelled out $225 million to acquire 100% of the equity in Mitobridge. The acquisition sets the tone for Astellas's further…
Read More...

WCG confirms the appointment of Shannon Bledsoe as its Executive Director. She will be responsible for overall organizational growth and strategic direction and overseeing the quality…
Read More...

Swedish Orphan Biovitrum AB confirmed FDA's acceptance of the investigational new drug application for the drug candidate SOBI003 along with granting Fast track status to it. SOBI003 is…
Read More...